Latest filing published 16 Jun 2025 for Exact Sciences CORP.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Daniel J. Levangie: trading record in brief
This profile gathers the share dealings of Daniel J. Levangie across 6 companies, led by Cytyc Corp, Exact Sciences Corp and ev3 Inc. The record holds 143 filings, for trades running from 27 October 2006 to 12 June 2025.
Market trades split into 14 purchases (€547k) and 40 sales (€60.5M). The net balance comes to €60.0M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 31 share grants and 51 option exercises.
Half of the purchases are above €28k and half below.
The record was last updated on 16 June 2025 with a share grant in Exact Sciences Corp. The last insider purchase was made public on 6 December 2013, 4,720 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Daniel J. Levangie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,398 shares0Common StockSEC:0000950170-25-086884:0
- 5,939 shares0Common StockSEC:0000950170-24-139094:0
- 5,444 shares0Common StockSEC:0000950170-24-074411:0
- 5,000 shares@ US$57.50100.0% of flowCommon StockSEC:0001209191-24-004241:0
- 4,678 shares0Common StockSEC:0001209191-23-036316:0
- 5,606 shares0Common StockSEC:0001209191-22-036402:0
- 2,675 shares0Common StockSEC:0001209191-21-044920:0
- 4,608 shares@ US$10.183.5% of flowCommon StockSEC:0001209191-20-044721:0
- 5,257 shares@ US$8.523.4% of flowCommon StockSEC:0001209191-20-044721:1
- 9,865 shares@ US$94.0069.5% of flowCommon StockSEC:0001209191-20-044721:2
- 2,558 shares0Common StockSEC:0001209191-20-043601:0
- 19,168 shares@ US$3.431.0% of flowCommon StockSEC:0001209191-19-044253:0
- 7,667 shares@ US$3.430.4% of flowCommon StockSEC:0001209191-19-044253:1
- 15,772 shares@ US$8.522.1% of flowCommon StockSEC:0001209191-19-044253:2
- 2,828 shares@ US$114.835.0% of flowCommon StockSEC:0001209191-19-044253:3
- 9,284 shares@ US$115.6516.6% of flowCommon StockSEC:0001209191-19-044253:4
- 2,300 shares@ US$116.474.1% of flowCommon StockSEC:0001209191-19-044253:5
- 9,572 shares@ US$117.7217.4% of flowCommon StockSEC:0001209191-19-044253:6
- 9,626 shares@ US$118.7317.6% of flowCommon StockSEC:0001209191-19-044253:7
- 8,897 shares@ US$119.6316.4% of flowCommon StockSEC:0001209191-19-044253:8
- 100 shares@ US$120.240.2% of flowCommon StockSEC:0001209191-19-044253:9
- 2,784 shares0Common StockSEC:0001209191-19-043378:0
- 4,401 shares0Common StockSEC:0001209191-18-044483:0
- 7,119 shares0Common StockSEC:0001209191-17-046737:0
- 15,156 shares0Common StockSEC:0001209191-16-134612:0
25 of 140 declarations
